Delivery Order SPE2DB20D9766-SPE2DB25FC1FG
- Not listed
- This is a $2,858.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the procurement of 4,566,523 units of the Nexplanon 68 mg implant, a long-acting reversible contraceptive device. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
- This is a $3,698.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,558,244,879 units of Nexplanon 68 mg implants, a contraceptive product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which allows the DLA to issue firm...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $13,886.20 firm fixed-price contract is for the delivery of 4,567,140,351 units of the Nexplanon 68 mg implant, a contraceptive medical device. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,565,282,597 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
- This is a $27,772.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,568,021,950 units of Nexplanon 68 mg implants, a contraceptive device, with a performance period through May 12, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of Nexplanon 68 mg implants, which are contraceptive devices. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that allows the...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $32,819.52 and covers the delivery of 4,562,313,640 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $10,720.35 contract is for the delivery of 4,565,110,029 Nexplanon 68 mg implants, a contraceptive device. This award is under a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
- SPE2DB20D9766Indefinite Delivery Contract
- SPE2DB20D9766-SPE2DB25FC1FGDelivery Order
This is a $16,663.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,471,568 units of the Nexplanon 68 mg implant, a contraceptive device. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, in support of the medical supply needs of military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to the Department of Defense healthcare system. The contract has no set-aside designation, and DMS Pharmaceutical Group has consistently secured federal contracts without specific set-aside requirements, leveraging its status as a woman-owned small business to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 4/4/25 |